Guide to the Primary Care Guidelines

Peter Smith

• Publisher: CRC Press
• Year: 2022
• Print ISBN: 9781857757347
• eBook ISBN: 9781000605105
• Edition: 4
• Topic: Medicine
• Subtopic: Family Medicine & General Practice

This interactive workbook covers all the physiological and pharmacological aspects of pain and pain control. Each topic such as the central nervous system the human experience of pain and pain management is concisely covered in nine separate sessions. The workbook includes activities assignments worked examples self-assessment questions relating to learning objectives and learner profiles to assess current knowledge. The style is clear with diagrams personal profiles resources and areas to make your own notes. It is a companion to the text listed below and is a valuable tool for initial training and professional development.

1

ASTHMA

Summary of stepwise management of asthma in adults

Figure 1.1 Effects of asthma on airways and alveoli

Figure 1.2 Effects of anti-asthmatic drugs

Figure 1.3 Adult peak flow chart

Adult asthma references

This guideline is from the following source:

1. Scottish Intercollegiate Guidelines Network and British Thoracic Society. British Guideline on the Management of Asthma: a national clinical guideline. Edinburgh: SIGN and BTS; 2008. Available at: www.sign.ac.uk/pdf/qrg101.pdf
2. Ducharme FM. Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: systematic review of current evidence. BMJ. 2003; 326(7390): 621.
3. Evidence Based Medicine. High-dose inhaled corticosteroids increase the risk for some systemic adverse effects in asthma. Evid Based Med. 1999; 4(6): 191.
4. Gallefoss F, Bakke PS. Impact of patient education and self-management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respir Med. 2000; 94(3): 279–87.
5. Harrison TW, Oborne J, Newton S, et al. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet. 2004; 363(9405): 271–5.
6. Nelson J, Strauss L, Skowronski M, et al. Effect of long-term salmeterol treatment on exercise-induced asthma. N Engl J Med. 1998; 339(3): 141–5.
7. Rodolfo JD, Solarte I, Fitzgerald JM. Asthma. BMJ Clinical Evidence. BMJ Publishing Group Ltd. 2005. Available at: www.clinicalevidence.com
8. Statement by the Royal College of Physicians of London, King’s Fund Centre, National Asthma Campaign. Guidelines for management of asthma in adults: I. Chronic persistent asthma [Statement by the British Thoracic Society]. BMJ. 1990; 301: 651–3.
9. Tee AKH, Koh MS, Gibson PG, et al. Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma. Cochrane Database Syst Rev. 2007; 2: CD001281.
10. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J. 2004; 24(5): 822–33.
11. Tierney WM, Rosener JF, Seshadri, R, et al. Assessing symptoms and peak expiratory flow rate as predictors of asthma exacerbations. J Gen Intern Med. 2004; 19(3): 237–42.

Summary of stepwise management of asthma in children aged 5–12

Figure 1.4 Children's peak flow chart

Children's asthma references

This guideline is based upon the following source:

1. Scottish Intercollegiate Guidelines Network and British Thoracic Society. British Guideline on the Management of Asthma: a national clinical guideline. Edinburgh: SIGN and BTS; 2008. Available at: www.sign.ac.uk/pdf/qrg101.pdf
2. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med. 2000; 343(15): 1064–9.
3. Doull IJ. The effect of asthma and its treatment on growth. Arch Dis Child. 2004; 89(1): 60–3.
4. Guevara JP, Ducharme FM, Keren R, et al. Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma. Cochrane Database Systs Rev. 2006; 2: CD003558.
5. Guevara JP, Wolf FM, Grum CM, et al. Effects of educational interventions for self management of asthma in children and adolescents: systematic review and meta- analysis. BMJ. 2003; 326(7402): 1308–9.
6. Knorr B, Franchi LM, Bisgaard H, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics. 2001; 108(3): e48.
7. National Institute for Health and Clinical Excellence. Guidance on the Use of Inhaler Systems (Devices) in Children under the Age of 5 Years with Chronic Asthma: NICE technology appraisal guidance 10. London: NICE; 2000. Available at: www.nice.org.uk/guidance/index.jsp?action=article&o=32074
8. National Institute for Health and Clinical Excellence. Inhaler Devices for Routine Treatment of Chronic Asthma in Older Children (Aged 5–15 Years): NICE technology appraisal guidance 38. London: NICE; 2002. Available at: www.nice.org.uk/TA38
9. Rachelefsky G. Treating exacerbations of asthma in childr...

Table of contents

• Cover
• Half Title
• Title Page
• Copyright Page
• Table of Contents
• Foreword
• Introduction
• About the author
• Acknowledgements
• 1 Asthma
• 2 Atrial fibrillation
• 3 Breast disease
• 4 Cervical cytology
• 5 COPD
• 6 Coronary heart disease
• 7 Depression
• 8 Diabetes
• 9 Dyspepsia
• 10 Eczema
• 11 Epilepsy
• 12 Growth charts
• 13 Heart failure
• 14 Hypertension
• 15 Hypothyroidism
• 16 Infertility
• 17 Osteoporosis
• 18 Otitis media
• 19 Post-menopausal bleeding
• 20 Prostatic hypertrophy
• 21 Sore throat
• 22 Stroke
• 23 Suspected cancer